Last reviewed · How we verify
NCT05829343: ROLADI
RObotic Versus LAparoscopic Colectomy for DIverticulitis.
trial testing Laparoscopic Left colectomy in Diverticular Diseases in 1,450 participants. Currently enrolling.
30 March 2025
Quick facts
| Lead sponsor | S.M. Misericordia Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,450 |
| Start date | 1 June 2023 |
| Primary completion | 30 March 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Laparoscopic Left colectomy
- Robotic left colectomy
Conditions studied
- Diverticular Diseases — all drugs for Diverticular Diseases →
- Diverticulitis — all drugs for Diverticulitis →
Sponsor
S.M. Misericordia Hospital
Who can join
18 and older, any sex, with Diverticular Diseases or Diverticulitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Over the last decade there has been a growing interest toward the application of robotic approach for diverticular disease. The evidence available on the literature showed that robotic approach, compared to the laparoscopic surgery, offers significant advantages in terms of conversion rate and shortened hospital stay for the treatment of diverticular disease. The investigators aimed at evaluating whether robotic colectomy may offer some advantages over the laparoscopic approach for surgical treatment of diverticular disease by analyzing a one year multicenter prospective study. Primary objective is to evaluate if robotic approach reduce the rate of conversion to open approach compared to laparoscopic surgery. Secondary objective is to assess difference between the two approaches in terms of rate of intraoperative complication, postoperative morbidities (according with Clavien and Dindo Classification), hospital stay and at one year follow up. Inclusion criteria are: elective colectomy for complicated or non-complicated diverticular disease performed with laparoscopic or robotic approach and age between 18 and 90 years. Exclusion criteria are non-elective colectomy (emergency resection), open procedure, diverticular resection performed during other procedure (i.e. colectomy for cancer). Data will be collected in one year from the start of the study. Due to the lack of available evidence, it is impossible to draw definitive conclusions. With this study, the investigators hope to clarify the role of the robotic approach in the treatment of diverticular disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Analyzing the switch from laparoscopic to robotic surgery for diverticular disease: a comparative cohort study.
Bhome R, Rajebhosale R, Smyth R, Martin E, et al · · 2025 · PMID 41428167 · DOI 10.1007/s11701-025-03061-2
Verify or expand the search:
- PubMed search for NCT05829343
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diverticular Diseases
Currently open trials in the same condition.
- NCT06797739 — Effect of Nutritional Counseling and Mediterranean Diet on Patients With Diverticular Disease · NA · active not recruiting
Other S.M. Misericordia Hospital trials
Trials by the same sponsor.
- NCT04686747 — COVID - 19 and Advanced Gastro-intestinal Cancer Treatment · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05829343 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by S.M. Misericordia Hospital
- Last refreshed: 29 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05829343.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing